Select Medical sees Q2 adjusted EPS 61c, consensus 48c

Sees Q2 revenue $1.67B, consensus $1.64B. Select Medical Holdings is currently in discussions with its lenders regarding a proposed refinancing of certain of its outstanding indebtedness. In connection with such discussions, Select Medical announced an estimate of certain financial results for its Q2 ended June 30 in advance of the announcement of actual results, which is expected to occur after market close on Thursday, August 3. Sees Q2 Adjusted EBITDA $219M. As of June 30 Select Medical expects approximately $100M of cash and $3.75B of indebtedness on its balance sheet. The above expectations regarding Select Medical’s financial results for the Q2 are management estimates and projections based on currently available information, and are subject to change upon completion of Select Medical’s financial statement closing process.